Evolent Health, Inc.·4

Mar 5, 5:12 PM ET

Stone Lydia 4

4 · Evolent Health, Inc. · Filed Mar 5, 2019

Insider Transaction Report

Form 4
Period: 2019-03-01
Stone Lydia
Principal Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2019-03-01+8,46523,855 total
  • Award

    Class A Common Stock Option (right to buy)

    2019-03-01+16,16416,164 total
    Exercise: $13.29Exp: 2029-03-01Class A Common Stock (16,164 underlying)
Footnotes (4)
  • [F1]Represents restricted stock units granted to Ms. Stone pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 25% annually beginning March 1, 2020.
  • [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F4]Securities vest at a rate of 25% annually beginning March 1, 2020.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT